Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
27 December 2022 - 10:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2022
Commission File Number: 001-41089
Advanced Health
Intelligence Ltd
(Translation of registrant’s name into English)
71-73 South Perth Esplanade, Unit 5
South Perth, WA 6151
Australia
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the
registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Note: Regulation S-T Rule 101(b)(1) only permits
the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the
registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Note: Regulation S-T Rule 101(b)(7) only permits
the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must
furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the
registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded,
as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's
security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing
on EDGAR.
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
Attached as Exhibit 99.1 to this Report on Form 6-K
is a copy of the press release of Advanced Health Intelligence Ltd, dated December 22, 2022: AHI granted 180 Day extension to NASDAQ Bid
Price Re-Compliance Period.
SIGNATURES
Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
ADVANCED HEALTH INTELLIGENCE LTD |
|
|
|
Date: December 23, 2022 |
By: |
/s/ Scott Montgomery |
|
|
Name: |
Scott Montgomery |
|
|
Title: |
Chief Executive Officer |
Advanced Health Intellig... (NASDAQ:AHI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Advanced Health Intellig... (NASDAQ:AHI)
Historical Stock Chart
From Apr 2023 to Apr 2024